Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

ACETAMINOPHEN ORAL SUSPENSION

Awarded
SPE2DP26F9478Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Logistics Agency Troop Support Medical Supply Chain awarded contract SPE2DP26F9478 to DMS Pharmaceutical Group Inc on September 2, 2026. This delivery order, issued under the broader base contract SPE2DX25D9900, is for the procurement of acetaminophen oral suspension, identified by NSN 6505013731444. The order falls under NAICS code 325412 for pharmaceutical manufacturing. The total contract price is 12.85 dollars for a quantity of five bottles. The agreement specifies FOB destination terms, with inspection and acceptance occurring at the destination. This specific order was processed as a delivery order for supplies and services, utilizing the administrative framework established by the primary commercial items contract effective since April 2, 2025.

General Info

DLA awarded DMS Pharmaceutical Group 12.85 dollars for five acetaminophen oral suspension bottles.

Contract Value

$12.85

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

2

SPE2DP26F9478 - Order for Supplies or Services

PDF, Low prioritydelivery-order
Low

SPE2DX-25-D-9900 Contract/Order for Commercial Items

PDF, Low prioritycontract-document
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F9478 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $12.85 Award Date: 09-02-2026 Delivery order under: SPE2DX25D9900 Line items: - ACETAMINOPHEN ORAL SUSPENSION (NSN/Part 6505013731444, PR 7018171102)

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
Federal
6505--Sacubitril/Valsartan Tablets (VA-27-00014055)
Solicitation # 36E79727R0007
The Department of Veterans Affairs Enterprise Procurement Office intends to award a single, unrestricted national mandatory requirements contract for an uninterrupted source of supply of Sacubitril-Valsartan Tablets. This procurement, issued under NAICS code 325412 and FAR Part 12, supports multiple federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will span a one-year base period with four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to execute necessary chargeback agreements to ensure timely delivery. The successful offeror must provide a unique eleven-digit National Drug Code (NDC) where the first five digits identify the offeror, and this must be the only label on the product. Strict packaging specifications are required for 60 and 180 count bottles, including a minimum volume of 120cc, a cylindrical body with at least a 5.75 inch circumference, and a safety cap that is either convertible or deshellable. Bottles must accommodate a 5.25 by 2 inch label with an additional 0.5 inch of space for barcodes and expiration data. Offerors who are not the manufacturer must provide a letter of commitment ensuring a sufficient source of supply. The solicitation is expected to be issued around December 18, 2026, with a tentative closing date of January 7, 2027.
Nac Pharmaceuticals (36E797)

POSTED

about 15 hours ago

DEADLINE

in 12 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS